[Telemedicine in heart failure : Evidence, benefits and future perspectives].

Abstract

In recent years telemonitoring for heart failure (TmHi) has transitioned from project-based pilot applications to a structured and fully reimbursed component of routine outpatient care in Germany. This development is supported by robust evidence from randomized controlled trials and meta-analyses demonstrating consistent reductions in mortality and hospitalizations, improved treatment adherence and enhanced continuity of care. Both noninvasive and implant-based monitoring strategies enable early detection of pathophysiological deterioration and facilitate proactive therapeutic adjustments through telemedicine centers (TMZ) in close collaboration with primary physicians. The implementation of TmHi in Germany relies on clear legal, technical and organizational standards, although current practice across centers remains heterogeneous and reveals potential for improvement in workflow standardization, interoperability, staffing and reimbursement management. In addition to the proven clinical benefits, in the context of the demographic changes TmHi is gaining in importance economically and in the healthcare system. Telemonitoring is thus poised to evolve from a specialized adjunct service into a cornerstone of predictive, digitally integrated care of heart failure.